share_log
Moomoo 24/7 ·  Apr 22 07:39
Kura Oncology Shares Are Trading Higher After the Company Received FDA Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AML
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment